, Tracking Stock Market Picks
Enter Symbol:
Anesiva, Inc. (ANSVQ) [hlAlert]

Strong Buy
down 99.93 %

Anesiva, Inc. (ANSV) rated Strong Buy with price target $12.15 by Broadpoint Capital

Posted on: Wednesday,  Jan 2, 2008  10:42 AM ET by Broadpoint Capital

Broadpoint Capital rated Strong Buy Anesiva, Inc. (OTCBB: ANSVQ) on 01/02/2008, when the stock price was $5.00.
Since then, Anesiva, Inc. has lost 99.94% as of 01/10/2012's recent price of $0.00.
If you would have followed this Broadpoint Capital's recommendation on ANSVQ, you would have lost 99.93% of your investment in 1469 days.

Anesiva, Inc. (Anesiva) is a biopharmaceutical company focused on the development and commercialization of therapeutic treatments for pain management. Its portfolio includes two products. Adlea, a long-acting, site-specific, non-opioid analgesic, is being developed for moderate to severe pain, and has completed multiple Phase II trials in post-surgical, musculoskeletal and neuropathic pain and Phase III trials in bunionectomy and total knee arthroplasty (TKA, or total knee replacement surgery). The Company is initially pursuing an indication for Adlea for the management of acute pain associated with orthopedic surgeries. Zingo (lidocaine hydrochloride monohydrate) powder intradermal injection system, was approved by the Food and Drug Administration (FDA) in August 2007, to reduce the pain associated with peripheral intravenous (IV) insertions or blood draws in children 3 to 18 years of age. Zingo was approved in January 2009, to reduce the pain associated with blood draws in adults.

Broadpoint Capital, Inc. is an investment banking and capital markets firm that provides corporate and public finance services and trading of corporate, government, and municipal securities for institutions. The company has three divisions: Municipal Capital Markets division, which underwrites and trades municipal securities in new issue and secondary markets; Taxable Fixed Income division, which is a dealer focusing on fixed income securities with limited liquidity; and Equity Capital Markets division, which is a sector-focused investment banking group providing research, trading, raising of capital and advisory services for institutional and corporate clients. Broadpoint Capital, formerly known as First Albany Corporation, was founded in 1953 and is based in New York, New York. The company operates as a subsidiary of First Albany Companies Inc.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/2/2008 10:42 AM Buy
5.00 12.15
as of 12/24/2008
1 Week down  -3.84 %
1 Month   
3 Months down  -50.00 %
1 YTD down  -28.57 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy